首页> 外文期刊>Antimicrobial agents and chemotherapy. >Inducible Cell Fusion Permits Use of Competitive Fitness Profiling in the Human Pathogenic Fungus Aspergillus fumigatus
【24h】

Inducible Cell Fusion Permits Use of Competitive Fitness Profiling in the Human Pathogenic Fungus Aspergillus fumigatus

机译:诱导型细胞融合允许在人致病性真菌曲霉病中使用竞争性健身谱

获取原文
获取原文并翻译 | 示例
           

摘要

Antifungal agents directed against novel therapeutic targets are required for treating invasive, chronic, and allergic Aspergillus infections. Competitive fitness profiling technologies have been used in a number of bacterial and yeast systems to identify druggable targets; however, the development of similar systems in filamentous fungi is complicated by the fact that they undergo cell fusion and heterokaryosis. Here, we demonstrate that cell fusion in Aspergillus fumigatus under standard culture conditions is not predominately constitutive, as with most ascomycetes, but can be induced by a range of extracellular stressors. Using this knowledge, we have developed a barcode-free genetic profiling system that permits high-throughput parallel determination of strain fitness in a collection of diploid A. fumigatus mutants. We show that heterozygous cyp51A and arf2 null mutants have reduced fitness in the presence of itraconazole and brefeldin A, respectively, and a heterozygous atp17 null mutant is resistant to brefeldin A.
机译:针对新的治疗靶标的抗真菌剂是治疗侵袭性,慢性和过敏性曲霉感染所必需的。竞争性健康分析技术已用于许多细菌和酵母系统中以识别可药剂目标;然而,由于它们经历细胞融合和异核病症的事实,丝状真菌的类似系统的发展变得复杂。在这里,我们证明,在标准培养条件下的曲霉菌中的细胞融合不是主要的构成型,与大多数依赖性,但可以通过一系列细胞外压力源引起的。使用这种知识,我们开发了一种无条条形码遗传分析系统,允许高通量并行测定类二倍体突变体的集合中的应变适应性。我们表明,杂合CYP51A和ARF2空突变体分别在伊唑康唑和Brefeldin A存在下减少健康,杂合的ATP17空突变体是抗Brefeldin A的抗性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号